RSS-Feed abonnieren
DOI: 10.1055/a-2052-8912
Fecal Occult Blood Screening before Cardiac Surgery
![](https://www.thieme-connect.de/media/thoracic/202401/lookinside/thumbnails/10-1055-a-2052-8912_1120226773oc-1.jpg)
Abstract
Background Concerns of gastrointestinal (GI) bleeding after cardiac surgery are increasing with increased use of antiplatelets and anticoagulants. We investigated the roles of preoperative screening for fecal occult blood by fecal immunochemical test (FIT) widely used to detect GI bleeding and cancer.
Methods A retrospective review was done in 1,663 consecutive patients undergoing FIT before cardiac surgery between years 2012 and 2020. One or two rounds of FIT were performed 2 to 3 weeks before surgery, when antiplatelets and anticoagulants were not suspended yet.
Results Positive FIT (> 30 μg of hemoglobin/g of feces) was observed in 227 patients (13.7%). Preoperative risk factors for positive FIT included age > 70 years, anticoagulants, and chronic kidney disease. Of those with positive FIT, 180 patients (79%) received preoperative endoscopy, including gastroscopy (n = 139), colonoscopy (n = 9), and both (n = 32), with no findings of bleeding. The most common finding of gastroscopy was atrophic gastritis (36%) while early gastric cancer was detected in 2 patients. The most common finding of colonoscopy was colon polyps (42%) while colorectal cancer was detected in 5 patients. Of 180 FIT-positive patients receiving endoscopy, 8 (4.4%) underwent preoperative GI treatment, while postoperative GI events were documented in 28 (15.6%). Of 1,436 with negative FIT, 21 (1.5%) presented GI complications after surgery.
Conclusion Preoperative FIT, which is influenced by anticoagulant use, has little impacts on identification of GI bleeding sites. However, it may be useful to detect GI malignant lesions, potentially impacting operative risks, surgical strategies, and postoperative management.
Keywords
gastrointestinal bleeding - fecal occult blood - fecal immunochemical test - colorectal cancerPublikationsverlauf
Eingereicht: 30. November 2022
Angenommen: 09. März 2023
Accepted Manuscript online:
13. März 2023
Artikel online veröffentlicht:
21. April 2023
© 2023. Thieme. All rights reserved.
Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany
-
References
- 1 Viana FF, Chen Y, Almeida AA, Baxter HD, Cochrane AD, Smith JA. Gastrointestinal complications after cardiac surgery: 10-year experience of a single Australian centre. ANZ J Surg 2013; 83 (09) 651-656
- 2 Krawiec F, Maitland A, Duan Q, Faris P, Belletrutti PJ, Kent WDT. Duodenal ulcers are a major cause of gastrointestinal bleeding after cardiac surgery. J Thorac Cardiovasc Surg 2017; 154 (01) 181-188
- 3 Hess NR, Seese LM, Hong Y. et al. Gastrointestinal complications after cardiac surgery: incidence, predictors, and impact on outcomes. J Card Surg 2021; 36 (03) 894-901
- 4 Elgharably H, Gamaleldin M, Ayyat KS. et al. Serious gastrointestinal complications after cardiac surgery and associated mortality. Ann Thorac Surg 2021; 112 (04) 1266-1274
- 5 Loffredo L, Perri L, Violi F. Impact of new oral anticoagulants on gastrointestinal bleeding in atrial fibrillation: a meta-analysis of interventional trials. Dig Liver Dis 2015; 47 (05) 429-431
- 6 García Rodríguez LA, Martín-Pérez M, Hennekens CH, Rothwell PM, Lanas A. Bleeding risk with long-term low-dose aspirin: a systematic review of observational studies. PLoS One 2016; 11 (08) e0160046
- 7 Lorusso R, Vizzardi E, Johnson DM. et al. Cardiac surgery in adult patients with remitted or active malignancies: a review of preoperative screening, surgical management and short- and long-term postoperative results. Eur J Cardiothorac Surg 2018; 54 (01) 10-18
- 8 Kanda Y. Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics. Bone Marrow Transplant 2013; 48 (03) 452-458
- 9 Imperiale TF, Ransohoff DF, Itzkowitz SH. et al. Multitarget stool DNA testing for colorectal-cancer screening. N Engl J Med 2014; 370 (14) 1287-1297
- 10 Chiu HM, Jen GH, Wang YW. et al. Long-term effectiveness of faecal immunochemical test screening for proximal and distal colorectal cancers. Gut 2021; 70 (12) 2321-2329
- 11 Mankaney G, Sutton RA, Burke CA. Colorectal cancer screening: choosing the right test. Cleve Clin J Med 2019; 86 (06) 385-392
- 12 Zappa M, Visioli CB, Ciatto S. et al. Gastric cancer after positive screening faecal occult blood testing and negative assessment. Dig Liver Dis 2007; 39 (04) 321-326
- 13 He E, Alison R, Blanks R. et al. Association of ten gastrointestinal and other medical conditions with positivity to faecal occult blood testing in routine screening: a large prospective study of women in England. Int J Epidemiol 2019; 48 (02) 549-558
- 14 Ng JY, Chan DK, Tan KK. Is gastroscopy for fecal immunochemical test positive patients worthwhile?. Int J Colorectal Dis 2017; 32 (01) 95-98
- 15 Choi JS, Choi JY, Cho HG. et al. Is esophagogastroduodenoscopy necessary in patients with positive fecal occult blood tests and negative colonoscopy?. Scand J Gastroenterol 2013; 48 (06) 657-662
- 16 Holster IL, Valkhoff VE, Kuipers EJ, Tjwa ETTL. New oral anticoagulants increase risk for gastrointestinal bleeding: a systematic review and meta-analysis. Gastroenterology 2013; 145 (01) 105-112.e15
- 17 Cea Soriano L, Lanas A, Soriano-Gabarró M, García Rodríguez LA. Incidence of upper and lower gastrointestinal bleeding in new users of low-dose aspirin. Clin Gastroenterol Hepatol 2019; 17 (05) 887-895.e6
- 18 Niikura R, Yamada A, Fujishiro M. et al. The effects of direct oral anticoagulants, warfarin, aspirin and thienopyridine on the performance of immunochemical, faecal, occult blood tests. Digestion 2019; 100 (02) 117-126
- 19 Robertson DJ, Lee JK, Boland CR. et al. Recommendations on fecal immunochemical testing to screen for colorectal neoplasia: a consensus statement by the US multi-society task force on colorectal cancer. Gastroenterology 2017; 152 (05) 1217-1237.e3
- 20 Randel KR, Botteri E, Romstad KMK. et al. Effects of oral anticoagulants and aspirin on performance of fecal immunochemical tests in colorectal cancer screening. Gastroenterology 2019; 156 (06) 1642-1649.e1
- 21 Krishnan S, Eslick GD. Streptococcus bovis infection and colorectal neoplasia: a meta-analysis. Colorectal Dis 2014; 16 (09) 672-680
- 22 García-Albéniz X, Hsu J, Lipsitch M, Logan RW, Hernández-Díaz S, Hernán MA. Infective endocarditis and cancer in the elderly. Eur J Epidemiol 2016; 31 (01) 41-49
- 23 Alimi Y, Sosin M, Borsinger TM, Garrett JR, Salameh JR, Espinel CF. Implications of Clostridium septicum in vascular surgery: a case report and outcomes literature review. Ann Vasc Surg 2017; 43 (05) 314.e5-314.e11